Analyst Explains Why He's Bearish On Tilray And Aurora Cannabis, Recommends MSOs


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


GLJ Research founder Gordon Johnson joined Benzinga’s PreMarket Prep show on June 23. During the discussion, Johnson weighed in on Canadian cannabis stocks, which have made a major comeback since the market bottom in March.

Johnson said the best data on the Canadian cannabis market is from Stats Canada, and recent trends are not encouraging.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

“In March, Canadian cannabis sales skyrocketed. What happened? Everybody got scared. They thought we were going to be locked in for a long time, so people stocked up on inventory,” Johnson said.

Cannabis Stocks Rally

As a result, cannabis investors thought the Canadian market had finally reached a turning point after sales growth softened throughout 2019. Canadian cannabis stocks, including Tilray Inc (NASDAQ:TLRY) and Aurora Cannabis Inc (NYSE:ACB) surged higher on the March sales data.

“So then, fast forward and we got April sales data last week. Guess what? Sales down in April,” Johnson said.

Given the large cannabis inventory levels in Canada, Johnson said cannabis stocks need consistent growth in sales or cannabis prices will face significant pressure. New cannabis store openings were down in April and cannabis prices have been down in June as well.


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


“There’s a lot of optimism priced into these stocks. Aurora is trading at an EV-to-sales multiple of 5.5x. The MSOs in the U.S., who actually generate positive EBITDA, are trading at less than half that. So I think what happens is Q2 numbers come out, and I think they’re going to be a big disappointment, not just from a volume perspective but from a margin perspective,” Johnson said.

How To Play It

Johnson predicted large cash burns from Canadian cannabis producers but said US MSOs should perform relatively well in the quarter.

“I think the stocks trade off significantly. And when I say the stocks, I’m talking about Aurora and Tilray,” he said. “I’d be short Aurora, I’d be short Tilray. On the flip side of that, you may look positively on some of the U.S. MSOs.”

Johnson specifically mentioned Trulieve Cannabis Corp (OTC:TCNNF) and Curaleaf Holdings Inc (OTC:CURLF) as two U.S. MSOs that are performing relatively well when it comes to EBITDA.

Watch to the full interview with Gordon Johnson in the clip below, or listen to the podcast here

< >

PreMarket Prep is a daily trading show hosted by prop trader Dennis Dick and former floor trader Joel Elconin. You can watch PreMarket Prep live every day from 8-9 a.m. ET here. The replay can be found on Benzinga's YouTube channel, and the podcast is on iTunes, Google PlaySoundcloudStitcher and Tunein.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorCannabisLong IdeasShort IdeasMarketsAnalyst RatingsTrading IdeasGLJ ResearchGordon Johnson